Meta-analysis of 7,048 first-time stroke patients across six countries reports post-stroke cognitive impairment incidence rates.
A systematic review and meta-analysis pooled data from studies involving 7,048 first-time stroke patients across six countries to assess the incidence of post-stroke cognitive impairment (PSCI). The analysis stratified patients by sex, stroke subtype, comorbidities, and age to explore variability in outcomes. No specific medication interventions were evaluated in this observational synthesis.
The overall incidence of PSCI was 46% (95% CI 36–57). Subgroup analyses indicated that PSCI prevalence was 45% in females compared to 38% in males. Patients with hemorrhagic stroke exhibited a prevalence of 54%, whereas ischemic stroke patients had a prevalence of 44%. Comorbidities also influenced risk; patients with hypertension showed a 38% prevalence versus 32% in those without, while those with diabetes had a 44% prevalence compared to 36% without. Similarly, hyperlipidemia was associated with a 46% prevalence versus 40% in patients without this condition. Patients aged over 60 years had a 44% incidence.
Safety and tolerability data were not reported. A critical limitation of this meta-analysis was substantial statistical heterogeneity, with an I² statistic of 98.63%, suggesting significant variation between included studies. Funding sources and potential conflicts of interest were not reported. Because the evidence is observational, causal inferences regarding specific risk factors cannot be made. Clinicians should recognize these high baseline rates of cognitive impairment in diverse stroke populations when planning long-term care and rehabilitation strategies.